Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jason Shackelford Insider Profile
11 Followers
Jason Shackelford, Prin Fin. & Acct. Officer at Oncternal Therapeutics, holds 19.55K shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Jason Shackelford Sold $9,279 shares of Oncternal Therapeutics on Jun 22, 2018 for an estimated value of 176.30K.
Jason Shackelford Oncternal Therapeutics (ONCT)Prin Fin. & Acct. Officer
Oncternal Therapeutics (ONCT)
Prin Fin. & Acct. Officer
Ranked #12,494 out of 78,624 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+61.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jason Shackelford's holdings
Insider Roles
Prin Fin. & Acct. Officer
Roles that Jason Shackelford holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 22, 2018 - Jun 22, 2019
Return:+94.30%
The most profitable trade made by Jason Shackelford
Jason Shackelford's Trading History
List of latest transactions for each holding click on a transaction to see Jason Shackelford's performance on stock
You May Also Like
Jason Shackelford insider profile FAQ
What is the percentage of profitable transactions made by Jason Shackelford?
The percentage of profitable transactions made by Jason Shackelford is 67%.
What is the average return per transaction made by Jason Shackelford?
The average return per transaction made by Jason Shackelford is 61.70%.
What stocks does Jason Shackelford hold?
Jason Shackelford holds: ONCT stocks.
What was Jason Shackelford’s latest transaction?
Jason Shackelford latest transaction was an Informative Sell of $176.30K.
What was Jason Shackelford's most profitable transaction?
Jason Shackelford’s most profitable transaction was an Informative Sell of ONCT stock on June 22, 2018. The return on the trade was 94.30%.
What is Jason Shackelford's role in Oncternal Therapeutics?
Jason Shackelford's role in Oncternal Therapeutics is Prin Fin. & Acct. Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.